Evidence map›Paper›PMID 40358510›Full record

ArticleBioinformatics (Oxford, England)2025

Relation equivariant graph neural networks to explore the mosaic-like tissue architecture of kidney diseases on spatially resolved transcriptomics.

Mauminah Raina, Hao Cheng, Ricardo Melo Ferreira, Treyden Stansfield, Chandrima Modak, Ying-Hua Cheng, Hari Naga Sai Kiran Suryadevara, Dong Xu, Michael T Eadon, Qin Ma and 1 more

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mauminah RainaDepartment of Biomedical Engineering and Informatics, Indiana University Indianapolis, Indianapolis, IN 46202, United States.
Hao ChengDepartment of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH 43210, United States.
Ricardo Melo FerreiraDepartment of Medicine, Indiana University, Indianapolis, IN 46202, United States.
Treyden StansfieldDepartment of Biomedical Engineering and Informatics, Indiana University Indianapolis, Indianapolis, IN 46202, United States.
Chandrima ModakDepartment of Biomedical Engineering and Informatics, Indiana University Indianapolis, Indianapolis, IN 46202, United States.
Ying-Hua ChengDepartment of Medicine, Indiana University, Indianapolis, IN 46202, United States.
Hari Naga Sai Kiran SuryadevaraDepartment of Biomedical Engineering and Informatics, Indiana University Indianapolis, Indianapolis, IN 46202, United States.
Dong XuDepartment of Electrical Engineering and Computer Science, and Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, MO 65211, United States.ORCID 0000-0002-4809-0514
Michael T EadonDepartment of Medicine, Indiana University, Indianapolis, IN 46202, United States.
Qin MaDepartment of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH 43210, United States.ORCID 0000-0002-3264-8392
Juexin WangDepartment of Biomedical Engineering and Informatics, Indiana University Indianapolis, Indianapolis, IN 46202, United States.ORCID 0000-0002-2260-4310

Funding

Central Hub for Kidney Precision MedicineU24DK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI Jonathan Himmelfarb, Matthias Kretzler · 2022 to 2026
$21.1M
TriState SenNET (Lung and Heart) Tissue Map and Atlas consortiumU54AG075931 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TOREN FINKEL, Melanie Koenigshoff · 2021 to 2026
$14.0M
KPMP Kidney Mapping and Atlas Project (KMAP)U01DK133090 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jonathan Himmelfarb, Matthias Kretzler · 2022 to 2026
$10.4M
Integrated spatial interrogation of cellular and molecular signatures of human kidney diseaseU01DK114923 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Tarek Maurice Ashkar, Pierre C Dagher · 2022 to 2026
$5.4M
Single cell multiomic and spatial atlas of acute and chronic kidney injuryU01DK114933 · NIDDK · WASHINGTON UNIVERSITY · PI Sanjay Jain · 2022 to 2026
$5.0M
Spatial Multi-Omics to Profile Metabolic Pathways for Kidney DiseaseU01DK114920 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Christopher R Anderton, Kumar Sharma · 2022 to 2026
$3.9M
Multi-view self-supervised deep learning for biological sequences and beyondR35GM126985 · NIGMS · UNIVERSITY OF SOUTH FLORIDA · PI DONG XU · 2018 to 2026
$3.8M
Boston Chronic Kidney Disease Research Biopsy CenterU01DK133092 · NIDDK · BOSTON MEDICAL CENTER · PI Sylvia E Rosas, Sushrut S. Waikar · 2022 to 2026
$3.5M
Multimodal Imaging Mass Spectrometry and Spatial Omics for the Human KidneyU01DK133766 · NIDDK · VANDERBILT UNIVERSITY · PI Jeffrey M Spraggins · 2022 to 2026
$3.4M
PREcision Medicine through IntErrogation of Rna in the kidnEy (PREMIERE)U01DK114907 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Nir Hacohen, Jeffrey Benton Hodgin · 2022 to 2026
$3.2M
University of Illinois at Chicago KPMP CKD Recruitment SiteU01DK133081 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JAMES P. LASH, Ana Catherine Ricardo · 2022 to 2026
$2.7M
AKI Matched Phenotype Linked Evaluation with Tissue (AMPLE-Tissue)U01DK114866 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Chirag R Parikh · 2022 to 2026
$2.6M
NHGRI NIH HHS R21 HG012482NIA NIH HHS U54 AG075931NIDDK NIH HHS U01 DK114866NIDDK NIH HHS U01DK114866NIDDK NIH HHS U01 DK114907NIDDK NIH HHS U01DK114907NIDDK NIH HHS U01 DK114908NIDDK NIH HHS U01DK114908NIDDK NIH HHS U01 DK114920NIDDK NIH HHS U01DK114920NIDDK NIH HHS U01 DK114923NIDDK NIH HHS U01DK114923NIDDK NIH HHS U01 DK114933NIDDK NIH HHS U01DK114933NIDDK NIH HHS U01 DK133081NIDDK NIH HHS U01DK133081NIDDK NIH HHS U01 DK133090NIDDK NIH HHS U01DK133090NIDDK NIH HHS U01 DK133091NIDDK NIH HHS U01DK133091NIDDK NIH HHS U01 DK133092NIDDK NIH HHS U01DK133092NIDDK NIH HHS U01 DK133093NIDDK NIH HHS U01DK133093NIDDK NIH HHS U01 DK133095NIDDK NIH HHS U01DK133095NIDDK NIH HHS U01 DK133097NIDDK NIH HHS U01DK133097NIDDK NIH HHS U01 DK133113NIDDK NIH HHS U01DK133113NIDDK NIH HHS U01 DK133766NIDDK NIH HHS U01DK133766NIDDK NIH HHS U01 DK133768NIDDK NIH HHS U01DK133768NIDDK NIH HHS U24 DK114886NIDDK NIH HHS U24DK114886NIDDK NIH HHS UH3 DK114861NIDDK NIH HHS UH3DK114861NIDDK NIH HHS UH3 DK114915NIDDK NIH HHS UH3DK114915NIDDK NIH HHS UH3 DK114926NIDDK NIH HHS UH3DK114926NIDDK NIH HHS UH3 DK114937NIDDK NIH HHS UH3DK114937NIGMS NIH HHS R35 GM126985NIH HHS R21HG012482NIH HHS R35GM126985NIH HHS U54AG075931Pelotonia Institute of Immuno-Oncology
6 · The paper itself

Abstract

motivationChronic kidney disease (CKD) and acute kidney injury (AKI) are prominent public health concerns affecting more than 15% of the global population. The ongoing development of spatially resolved transcriptomics (SRT) technologies presents a promising approach for discovering the spatial distribution patterns of gene expression within diseased tissues. However, existing computational tools are predominantly calibrated and designed on the ribbon-like structure of the brain cortex, presenting considerable computational obstacles in discerning highly heterogeneous mosaic-like tissue architectures in the kidney. Consequently, timely and cost-effective acquisition of annotation and interpretation in the kidney remains a challenge in exploring the cellular and morphological changes within renal tubules and their interstitial niches.

resultsWe present an empowered graph deep learning framework, REGNN (Relation Equivariant Graph Neural Networks), designed for SRT data analyses on heterogeneous tissue structures. To increase expressive power in the SRT lattice using graph modeling, REGNN integrates equivariance to handle n-dimensional symmetries of the spatial area, while additionally leveraging Positional Encoding to strengthen relative spatial relations of the nodes uniformly distributed in the lattice. Given the limited availability of well-labeled spatial data, this framework implements both graph autoencoder and graph self-supervised learning strategies. On heterogeneous samples from different kidney conditions, REGNN outperforms existing computational tools in identifying tissue architectures within the 10× Visium platform. This framework offers a powerful graph deep learning tool for investigating tissues within highly heterogeneous expression patterns and paves the way to pinpoint underlying pathological mechanisms that contribute to the progression of complex diseases. AVAILABILITY AND IMPLEMENTATION: REGNN is publicly available at https://github.com/Mraina99/REGNN.

Indexed as

Acute Kidney InjuryGene Expression ProfilingKidney DiseasesNeural Networks, ComputerRenal Insufficiency, ChronicTranscriptomeComputational BiologyDeep LearningGraph Neural NetworksHumansKidney

Identifiers

PMID40358510
PMCPMC12165735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.